CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $33.06M, lower than 95% of all stocks globally
- PositionOperating margin is -53.9%, lower than 95% of its Diagnostics & Research peers (median 5%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
24.48MGBP33.06M · vs all stocks (USD)
Revenue (TTM)
9.57MGBP12.93M · vs all stocks (USD)
Profit Margin
-33.88%vs Diagnostics & Research peers
Beta
0.1600xvs all stocks
52-Week Change
50.00%vs all stocks
Market Capitalization
24.48MGBP33.06M · vs all stocks (USD)
Enterprise Value
39.50MGBP53.34M · vs all stocks (USD)
Forward P/E
66.67xvs Diagnostics & Research peers
Price to Sales (TTM)
2.62xvs Diagnostics & Research peers
Price to Book (MRQ)
6.67xvs Diagnostics & Research peers
Enterprise to Revenue
4.13xvs Diagnostics & Research peers
Enterprise to EBITDA
-11.55xvs Diagnostics & Research peers
Profit Margin
-33.88%vs Diagnostics & Research peers
Operating Margin
-53.88%vs Diagnostics & Research peers
Return on Assets (TTM)
-24.37%vs Diagnostics & Research peers
Return on Equity (TTM)
-50.98%vs Diagnostics & Research peers
Revenue (TTM)
9.57MGBP12.93M · vs all stocks (USD)
Revenue per Share (TTM)
0.0250GBPUpdated Jul 21, 2026Quarterly Revenue Growth
36.90%vs Diagnostics & Research peers
Gross Profit (TTM)
3.96MGBP5.35M · vs all stocks (USD)
EBITDA (TTM)
-3.42MGBP-4.62M · vs all stocks (USD)
Net Income (TTM)
-3.24MGBP-4.38M · vs all stocks (USD)
Operating Cash Flow (TTM)
-2.27MGBP-3.07M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.47MGBP-1.98M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00GBPUpdated Jul 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Revenue
8.43MGBPFY2025 · Jun 30, 2025Cost of Goods Sold
4.69MGBPFY2025 · Jun 30, 2025Gross Profit
3.74MGBPFY2025 · Jun 30, 2025Operating Income
-3.51MGBP-4.74M · vs all stocks (USD)
Pre-tax Income
-3.50MGBPFY2025 · Jun 30, 2025Income Tax Expense
-81.00KGBPFY2025 · Jun 30, 2025Net Income
-3.42MGBPFY2025 · Jun 30, 2025EBIT
-3.41MGBPFY2025 · Jun 30, 2025EBITDA (Income Statement)
-2.80MGBPFY2025 · Jun 30, 2025Selling, General & Administrative
7.71MGBPFY2025 · Jun 30, 2025Non-operating Interest Income
100.00KGBPFY2025 · Jun 30, 2025Non-operating Interest Expense
87.00KGBPFY2025 · Jun 30, 2025EPS (Basic)
-0.0093GBPFY2025 · Jun 30, 2025EPS (Diluted)
-0.0093GBPFY2025 · Jun 30, 2025Basic Shares Outstanding
366.66MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
366.66MSharesFY2025 · Jun 30, 2025Net Income from Continuing Operations
-3.42MGBPFY2025 · Jun 30, 2025Preferred Stock Dividends
0.00GBPFY2025 · Jun 30, 2025Operating Cash Flow
-4.01MGBPFY2025 · Jun 30, 2025Free Cash Flow
-4.33MGBPFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
1.92MGBPFY2025 · Jun 30, 2025Starting Profit (CF Statement)
-3.42MGBPFY2025 · Jun 30, 2025Stock-based Compensation
214.00KGBPFY2025 · Jun 30, 2025Other Non-cash Items
-96.00KGBPFY2025 · Jun 30, 2025Change in Accounts Receivable (CF)
-624.00KGBPFY2025 · Jun 30, 2025Change in Other Assets/Liabilities
-85.00KGBPFY2025 · Jun 30, 2025Capital Expenditures
-327.00KGBPFY2025 · Jun 30, 2025Net Intangibles (CF)
-19.00KGBPFY2025 · Jun 30, 2025Net Acquisitions
-1.18MGBPFY2025 · Jun 30, 2025Net Investing Cash Flow
-1.51MGBPFY2025 · Jun 30, 2025Net Financing Cash Flow
5.63MGBPFY2025 · Jun 30, 2025Shares Outstanding
251.08MSharesUpdated Jul 21, 2026Float Shares
168.65MSharesUpdated Jul 21, 2026% Held by Insiders
29.20%vs all stocks
% Held by Institutions
30.76%vs all stocks
Total Cash (MRQ)
3.71MGBP5.01M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0090GBPUpdated Jul 21, 2026Total Debt (MRQ)
948.00KGBP1.28M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1505xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.91xvs Diagnostics & Research peers
Book Value per Share (MRQ)
0.0150GBPUpdated Jul 21, 2026Total Assets
9.31MGBP12.58M · vs all stocks (USD)
Total Current Assets
5.13MGBPFY2025 · Jun 30, 2025Total Liabilities
4.01MGBPFY2025 · Jun 30, 2025Total Non-current Assets
4.18MGBPFY2025 · Jun 30, 2025Total Non-current Liabilities
1.09MGBPFY2025 · Jun 30, 2025Total Current Liabilities
2.92MGBPFY2025 · Jun 30, 2025Cash & Cash Equivalents
1.92MGBPFY2025 · Jun 30, 2025Accounts Receivable
1.25MGBPFY2025 · Jun 30, 2025Inventory
526.00KGBPFY2025 · Jun 30, 2025Accounts Payable
765.00KGBPFY2025 · Jun 30, 2025Short-term Debt
261.00KGBPFY2025 · Jun 30, 2025Other Current Liabilities
340.00KGBPFY2025 · Jun 30, 2025Long-term Debt
767.00KGBPFY2025 · Jun 30, 2025Other Non-current Liabilities
236.00KGBPFY2025 · Jun 30, 2025Common Stock (Book)
49.00KGBPFY2025 · Jun 30, 2025Retained Earnings
-32.17MGBPFY2025 · Jun 30, 2025Total Shareholders' Equity
5.30MGBP7.16M · vs all stocks (USD)
52-Week Low
5.10GBXUpdated Jul 21, 202652-Week High
13.00GBXUpdated Jul 21, 202652-Week Change
50.00%vs all stocks
Beta
0.1600xvs all stocks
50-Day MA
11.25GBXUpdated Jul 21, 2026200-Day MA
8.20GBXUpdated Jul 21, 2026Avg 10-Day Volume
61.95KSharesUpdated Jul 21, 2026Avg 30-Day Volume
124.17KSharesUpdated Jul 21, 2026Diluted EPS (TTM)
-0.0100GBPUpdated Jul 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -53.9%, lower than 95% of its Diagnostics & Research peers (median 5%)Significant
Operating margin: -0.54Industry median: 0.05Industry P5: -0.34Peers compared: 31.00
Return on equity is -51%, lower than 95% of its Diagnostics & Research peers (median 1.1%)Significant
Return on equity: -0.51Industry median: 0.01Industry P5: -0.21Peers compared: 31.00
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.37Receivables vs revenue divergence: 3.89
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.91Altman Z-Score: -1.20
Financial Health
Altman Z-Score -1.2: distress zoneCritical
Altman Z-Score: -1.20
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $33.06M, lower than 95% of all stocks globallySignificant
Market cap (USD): 33,061,096.447Global P5: 269,387,740.27
Revenue is $12.93M, lower than 95% of all stocks globallySignificant
Revenue (USD): 12,927,273.16Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Verditek plc
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Harvard Bioscience, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Haydale Graphene Industries plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Mia Dynamics Motors Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
UTI Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Light Science Technologies Holdings plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Northern Bear Plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ct Automotive Group Plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hulamin Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Genedrive Plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking